NASDAQ:BCPC Balchem - BCPC Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Balchem Co. Please log in to your account or sign up in order to add this asset to your watchlist. $124.75 +0.61 (+0.49%) (As of 03/28/2023 12:00 AM ET) Add Compare Share Share Today's Range$122.99▼$125.0250-Day Range$121.34▼$142.0652-Week Range$110.15▼$143.88Volume88,169 shsAverage Volume105,567 shsMarket Capitalization$4.01 billionP/E Ratio38.38Dividend Yield0.57%Price Target$140.00 ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Balchem MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside12.2% Upside$140.00 Price TargetShort InterestHealthy0.99% of Float Sold ShortDividend StrengthStrongBased on Four FactorsSustainability-1.54Upright™ Environmental ScoreNews Sentiment0.46Based on 7 Articles This WeekInsider TradingSelling Shares$381,030 Sold Last QuarterProj. Earnings Growth20.00%From $3.60 to $4.32 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.73 out of 5 starsBasic Materials Sector28th out of 160 stocksChemicals & Allied Products Industry6th out of 15 stocks 2.5 Analyst's Opinion Consensus RatingBalchem has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $140.00, Balchem has a forecasted upside of 12.2% from its current price of $124.75.Amount of Analyst CoverageBalchem has received no research coverage in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.99% of the float of Balchem has been sold short.Short Interest Ratio / Days to CoverBalchem has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Balchem has recently increased by 25.12%, indicating that investor sentiment is decreasing significantly. Previous Next 3.3 Dividend Strength Dividend YieldBalchem has a dividend yield of 0.58%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthBalchem has been increasing its dividend for 12 years.Dividend CoverageThe dividend payout ratio of Balchem is 21.85%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Balchem will have a dividend payout ratio of 16.44% next year. This indicates that Balchem will be able to sustain or increase its dividend. Previous Next 2.3 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreBalchem has received a 6.99% net impact score from Upright. The largest positive contribution comes from its "Nutrition" impact, which is mostly driven by its "Whey proteins", "Soy proteins", and "Food preservatives" products. See details.Environmental SustainabilityThe Environmental Impact score for Balchem is -1.54. Previous Next 2.5 News and Social Media Coverage News SentimentBalchem has a news sentiment score of 0.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.29 average news sentiment score of Basic Materials companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Balchem this week, compared to 2 articles on an average week. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Balchem insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $381,030.00 in company stock.Percentage Held by InsidersOnly 1.60% of the stock of Balchem is held by insiders.Percentage Held by Institutions89.29% of the stock of Balchem is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Balchem are expected to grow by 20.00% in the coming year, from $3.60 to $4.32 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Balchem is 38.38, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 120.15.Price to Earnings Ratio vs. SectorThe P/E ratio of Balchem is 38.38, which means that it is trading at a less expensive P/E ratio than the Basic Materials sector average P/E ratio of about 88.02.Price to Book Value per Share RatioBalchem has a P/B Ratio of 4.27. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Balchem (NASDAQ:BCPC) StockBalchem Corp. provides marketing of specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health, Specialty Products and Industrial Products. The Human Nutrition and Health segment supplies ingredients in the food and beverage industry, providing customized solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems, and cereal systems. The Animal Nutrition and Health segment comprises nutritional products derived from microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment offers Ethylene oxide for the health care industry. The Industrial Products segment refers to certain derivatives of choline chloride which manufactured and sold into industrial applications as a component for hydraulic fracturing of shale natural gas wells. The company was founded in January 1967 and is headquartered in Montvale, NJ.Read More Receive BCPC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Balchem and its competitors with MarketBeat's FREE daily newsletter. Email Address BCPC Stock News HeadlinesMarch 27, 2023 | finance.yahoo.comAre Balchem Corporation's (NASDAQ:BCPC) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?March 25, 2023 | americanbankingnews.comBalchem Co. (NASDAQ:BCPC) Director Sells $381,030.00 in StockMarch 28, 2023 | Behind the Markets (Ad)Buy THIS stock before Taiwan is attacked... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.March 20, 2023 | americanbankingnews.comStockNews.com Initiates Coverage on Balchem (NASDAQ:BCPC)March 1, 2023 | finance.yahoo.comBalchem Corporation (NASDAQ:BCPC) Q4 2022 Earnings Call TranscriptFebruary 26, 2023 | finance.yahoo.comBalchem Full Year 2022 Earnings: EPS Misses ExpectationsFebruary 25, 2023 | finance.yahoo.comQ4 2022 Balchem Corp Earnings CallFebruary 24, 2023 | finance.yahoo.comBalchem Corporation Reports Fourth Quarter Net Sales Growth of 9.1% and Strong Full Year 2022 ResultsMarch 28, 2023 | Behind the Markets (Ad)Buy THIS stock before Taiwan is attacked... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.February 11, 2023 | finance.yahoo.comBalchem (NASDAQ:BCPC) sheds 4.3% this week, as yearly returns fall more in line with earnings growthFebruary 10, 2023 | finance.yahoo.comBalchem Corporation Announces Quarterly Conference Call for Fourth Quarter Financial Results on February 24, 2023January 6, 2023 | finance.yahoo.comDo Balchem's (NASDAQ:BCPC) Earnings Warrant Your Attention?January 6, 2023 | finance.yahoo.comBalchem Corporation Named on Newsweek’s 2023 List of America’s Most Responsible CompaniesJanuary 3, 2023 | finance.yahoo.comBalchem Corporation to Present at the CJS Securities 23rd Annual “New Ideas for the New Year” Investor Conference January 11, 2023November 9, 2022 | finance.yahoo.comIs Balchem Corporation (NASDAQ:BCPC) Expensive For A Reason? A Look At Its Intrinsic ValueNovember 4, 2022 | finance.yahoo.comBalchem Corporation Reports Third Quarter Sales of $244.3 Million, Net Earnings of $25.2 Million, GAAP EPS of $0.78, and Adjusted EPS of $1.00October 21, 2022 | finance.yahoo.comBalchem Corporation Announces Quarterly Conference Call for Third Quarter Financial Results on November 4, 2022October 17, 2022 | finance.yahoo.comSoftBank Sells THG Stake to Online Retailer’s Founder, Qatar After Share Drop - Yahoo FinanceOctober 17, 2022 | finance.yahoo.comBalchem Corporation's (NASDAQ:BCPC) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?October 10, 2022 | nasdaq.comBalchem Corporation's (NASDAQ:BCPC) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?October 8, 2022 | finance.yahoo.comBalchem Corporation (BCPC)October 3, 2022 | globenewswire.comGlobal Choline Bitartrate Market Size to grow USD 835.4 Million by 2030 | CAGR of 6.6% - GlobeNewswireSeptember 19, 2022 | nasdaq.comBlachem (BCPC) Moves to Strong Buy: Rationale Behind the Upgrade - NasdaqSeptember 19, 2022 | nasdaq.comBears are Losing Control Over Blachem (BCPC), Here's Why It's a 'Buy' Now - NasdaqSeptember 19, 2022 | finance.yahoo.comBears are Losing Control Over Blachem (BCPC), Here's Why It's a 'Buy' NowSeptember 12, 2022 | seekingalpha.comBalchem Stock: Acquisitions And Cost Pressures Draw Attention (NASDAQ:BCPC) - Seeking AlphaSeptember 7, 2022 | bizjournals.comNew York corporation acquires Vancouver's Bergstrom NutritionSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive BCPC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Balchem and its competitors with MarketBeat's FREE daily newsletter. Email Address BCPC Company Calendar Last Earnings10/28/2021Ex-Dividend for 1/20 Dividend12/23/2022Dividend Payable1/20/2023Today3/28/2023Next Earnings (Estimated)5/05/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Chemicals & allied products Sub-IndustrySpecialty Chemicals SectorBasic Materials Current SymbolNASDAQ:BCPC CUSIP05766520 CIK9326 Webwww.balchem.com Phone(845) 326-5600Fax845-326-5717Employees1,340Year Founded1967Price Target and Rating Average Stock Price Forecast$140.00 High Stock Price Forecast$140.00 Low Stock Price Forecast$140.00 Forecasted Upside/Downside+12.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)$3.25 Trailing P/E Ratio38.38 Forward P/E Ratio34.65 P/E GrowthN/ANet Income$105.37 million Net Margins11.18% Pretax Margin14.19% Return on Equity11.68% Return on Assets6.96% Debt Debt-to-Equity Ratio0.50 Current Ratio2.40 Quick Ratio1.54 Sales & Book Value Annual Sales$942.36 million Price / Sales4.26 Cash Flow$4.98 per share Price / Cash Flow25.07 Book Value$29.20 per share Price / Book4.27Miscellaneous Outstanding Shares32,170,000Free Float31,654,000Market Cap$4.01 billion OptionableOptionable Beta0.69 Social Links Key ExecutivesTheodore L. HarrisChairman, President & Chief Executive OfficerMartin BengtssonChief Financial Officer & Executive VPMichael SestrickChief Technology Officer & Senior Vice PresidentBrent TignorChief Human Resources Officer & Senior VPMartin L. ReidChief Supply Chain OfficerKey CompetitorsAshlandNYSE:ASHInnospecNASDAQ:IOSPLiventNYSE:LTHMChemoursNYSE:CCHuntsmanNYSE:HUNView All CompetitorsInsiders & InstitutionsMetLife Investment Management LLCSold 316 shares on 3/23/2023Ownership: 0.052%David B FischerSold 3,000 sharesTotal: $381,030.00 ($127.01/share)Voya Investment Management LLCBought 1,781 shares on 2/28/2023Ownership: 0.112%Trust Investment AdvisorsBought 1,688 shares on 2/28/2023Ownership: 0.005%Macquarie Group Ltd.Bought 4,789 shares on 2/21/2023Ownership: 0.655%View All Insider TransactionsView All Institutional Transactions BCPC Stock - Frequently Asked Questions Should I buy or sell Balchem stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Balchem in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BCPC shares. View BCPC analyst ratings or view top-rated stocks. What is Balchem's stock price forecast for 2023? 1 equities research analysts have issued 1-year price targets for Balchem's shares. Their BCPC share price forecasts range from $140.00 to $140.00. On average, they anticipate the company's share price to reach $140.00 in the next year. This suggests a possible upside of 12.2% from the stock's current price. View analysts price targets for BCPC or view top-rated stocks among Wall Street analysts. How have BCPC shares performed in 2023? Balchem's stock was trading at $122.11 at the beginning of 2023. Since then, BCPC stock has increased by 2.2% and is now trading at $124.75. View the best growth stocks for 2023 here. Are investors shorting Balchem? Balchem saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 315,300 shares, an increase of 25.1% from the February 28th total of 252,000 shares. Based on an average daily volume of 101,400 shares, the days-to-cover ratio is presently 3.1 days. Currently, 1.0% of the company's stock are short sold. View Balchem's Short Interest. When is Balchem's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, May 5th 2023. View our BCPC earnings forecast. How were Balchem's earnings last quarter? Balchem Co. (NASDAQ:BCPC) issued its earnings results on Thursday, October, 28th. The basic materials company reported $0.92 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.90 by $0.02. The basic materials company had revenue of $197.87 million for the quarter, compared to the consensus estimate of $204.80 million. Balchem had a trailing twelve-month return on equity of 11.68% and a net margin of 11.18%. During the same period in the prior year, the company earned $0.83 EPS. How often does Balchem pay dividends? What is the dividend yield for Balchem? Balchem declared an annual dividend on Tuesday, December 6th. Shareholders of record on Tuesday, December 27th will be paid a dividend of $0.71 per share on Friday, January 20th. This represents a dividend yield of 0.53%. The ex-dividend date is Friday, December 23rd. This is an increase from the stock's previous annual dividend of $0.64. Read our dividend analysis for BCPC. What ETFs hold Balchem's stock? ETFs with the largest weight of Balchem (NASDAQ:BCPC) stock in their portfolio include Invesco S&P SmallCap Materials ETF (PSCM), VanEck Future of Food ETF (YUMY), ProShares Russell 2000 Dividend Growers ETF (SMDV), SPDR S&P 600 Small Cap Growth ETF (SLYG), iShares S&P Small-Cap 600 Growth ETF (IJT), Vanguard S&P Small-Cap 600 Growth ETF (VIOG), Invesco S&P SmallCap Low Volatility ETF (XSLV) and Xtrackers S&P SmallCap 600 ESG ETF (SMLE). Is Balchem a good dividend stock? Balchem (NASDAQ:BCPC) pays an annual dividend of $0.71 per share and currently has a dividend yield of 0.58%. The company has been increasing its dividend for 12 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 21.85%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, BCPC will have a dividend payout ratio of 16.44% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for BCPC. What is Dino A. Rossi's approval rating as Balchem's CEO? 25 employees have rated Balchem Chief Executive Officer Dino A. Rossi on Glassdoor.com. Dino A. Rossi has an approval rating of 85% among the company's employees. 62.0% of employees surveyed would recommend working at Balchem to a friend. What other stocks do shareholders of Balchem own? Based on aggregate information from My MarketBeat watchlists, some companies that other Balchem investors own include Ecolab (ECL), CVS Health (CVS), AbbVie (ABBV), Johnson & Johnson (JNJ), Lowe's Companies (LOW), Altria Group (MO), NVIDIA (NVDA), AT&T (T), Analog Devices (ADI) and Bristol-Myers Squibb (BMY). What is Balchem's stock symbol? Balchem trades on the NASDAQ under the ticker symbol "BCPC." Who are Balchem's major shareholders? Balchem's stock is owned by many different retail and institutional investors. Top institutional investors include Conestoga Capital Advisors LLC (3.24%), Geneva Capital Management LLC (2.34%), Schroder Investment Management Group (2.17%), Dimensional Fund Advisors LP (2.04%), Geode Capital Management LLC (1.96%) and Clearbridge Investments LLC (1.59%). Insiders that own company stock include David B Fischer, Gunsteren Job Leonard Van, Scott C Mason and William A Backus. View institutional ownership trends. How do I buy shares of Balchem? Shares of BCPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Balchem's stock price today? One share of BCPC stock can currently be purchased for approximately $124.75. How much money does Balchem make? Balchem (NASDAQ:BCPC) has a market capitalization of $4.01 billion and generates $942.36 million in revenue each year. The basic materials company earns $105.37 million in net income (profit) each year or $3.25 on an earnings per share basis. How many employees does Balchem have? The company employs 1,340 workers across the globe. Does Balchem have any subsidiaries? The following companies are subsidiares of Balchem: Aberco Inc., Aberco Inc., Albion Laboratories Inc., Albion Laboratories Inc., BCP Ingredients Inc., Balchem BV, Balchem Italia Srl, Balchem Ltd., Balchem NV, Balchem Pte Ltd., Balchem Pty Ltd., Balchem Sdn Bhd, Bioscreen technologies, Chemogas Holding NV, Chol-Mix Kft, Innovative Food Processors, SensoryEffects, SensoryEffects Cereal Systems Inc., SensoryEffects Inc., Stereo Gas Philippines Inc., and Zumbro River Brand Inc..Read More How can I contact Balchem? Balchem's mailing address is 52 Sunrise Park Road, NEW HAMPTON NY, 10958. The official website for the company is www.balchem.com. The basic materials company can be reached via phone at (845) 326-5600, via email at mabrush@balchem.com, or via fax at 845-326-5717. This page (NASDAQ:BCPC) was last updated on 3/28/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.